![Medical News Asia | Powered by ['mediPr]](https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png)
Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
There is no excerpt because this is a protected post.
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
Rheumatic diseases are characterised by autoimmunity with autoantibody production against individuals’ own tissues. Although patients may present with a spectrum of symptoms ranging from localised to systemic manifestations, they are generally categorised according to the structures predominantly involved…
Psoriasis biologics may help reduce coronary plaque
While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.
